USFDA3 Nov 2026, 05:51 pm
Choksi Laboratories: USFDA Inspection Closed
AI Summary
Choksi Laboratories Ltd has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA). This report indicates the closure of the inspection conducted at the company's central laboratory in Indore from August 17 to August 20, 2026. The company had previously intimated about this inspection on August 21, 2026. This closure signifies a positive regulatory outcome for the company.
Key Highlights
- USFDA inspection at the central laboratory has been closed.
- Company received the Establishment Inspection Report (EIR).
- Regulatory compliance milestone achieved.
- Positive development for the company's operations.
Price Impact
More from CHOKSILA